Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3',4',5,7-tetrahydroxy-flavone
2. 3',4',5,7-tetrahydroxyflavone
3. Luteoline
1. 491-70-3
2. Digitoflavone
3. Luteolol
4. 3',4',5,7-tetrahydroxyflavone
5. Flacitran
6. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4h-chromen-4-one
7. Luteoline
8. Salifazide
9. Weld Lake
10. Yama Kariyasu
11. Cyanidenon 1470
12. Bismite
13. 5,7,3',4'-tetrahydroxyflavone
14. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one
15. C.i. Natural Yellow 2
16. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-benzopyrone
17. Daphneflavonol
18. Flavopurpol
19. 4h-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-
20. Cyanidenon-1470
21. Brn 0292084
22. Mfcd00017309
23. Kux1znc9j2
24. Chembl151
25. Flavone, 3',4',5,7-tetrahydroxy-
26. Chebi:15864
27. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4h-1-benzopyran-4-one
28. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-chromenone
29. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chromen-4-one
30. 1318-21-4
31. Smr000326896
32. 7-tetrahydroxyflavone
33. Ccris 3790
34. Sr-01000779333
35. Einecs 207-741-0
36. Unii-kux1znc9j2
37. Argemexitin
38. C.i. 75590
39. 4dew
40. 4dgn
41. 4hkn
42. Luteolin,(s)
43. Lu2
44. Prestwick_122
45. Luteolin [inci]
46. Luteolin [mi]
47. Prestwick0_000870
48. Prestwick1_000870
49. Prestwick2_000870
50. Prestwick3_000870
51. Luteolin [who-dd]
52. Bidd:pxr0059
53. Lopac0_000660
54. Oprea1_849964
55. Schembl20426
56. Bspbio_000919
57. Luteolin, Analytical Standard
58. Mls000697655
59. Mls000860038
60. Mls002154043
61. Mls006011917
62. Bidd:er0122
63. Spbio_002840
64. Bdbm7459
65. Bpbio1_001011
66. Gtpl5215
67. Megxp0_000143
68. Dtxsid4074988
69. Acon1_000223
70. Cid_5280445
71. Hms1570n21
72. Hms2097n21
73. Hms2220c06
74. Hms3356l02
75. Hms3561n09
76. Hms3649n21
77. Hms3656a05
78. Hms3714n21
79. Luteolin, >=99.0% (tlc)
80. Bcp03511
81. Hy-n0162
82. Tnp00073
83. Luteolin, >=98% (tlc), Powder
84. Bbl027837
85. Lmpk12110006
86. S2320
87. Stk801923
88. Zinc18185774
89. Akos002140588
90. Ac-1125
91. Bcp9000865
92. Ccg-208309
93. Cs-4611
94. Db15584
95. Ks-5202
96. Luteolin 100 Microg/ml In Acetonitrile
97. Smp2_000042
98. Ncgc00016467-01
99. Ncgc00016467-02
100. Ncgc00016467-03
101. Ncgc00016467-04
102. Ncgc00016467-05
103. Ncgc00016467-06
104. Ncgc00016467-07
105. Ncgc00016467-08
106. Ncgc00016467-21
107. Ncgc00142375-01
108. Ncgc00142375-02
109. Ncgc00142375-03
110. Ncgc00179375-01
111. Ncgc00179375-02
112. Cas-491-70-3
113. Sy030155
114. Bcp0726000198
115. Ft-0600053
116. N1831
117. Sw196433-3
118. T2682
119. 91l703
120. C01514
121. L 9283
122. S00110
123. A827664
124. Luteolin, Primary Pharmaceutical Reference Standard
125. Q415011
126. Q-100551
127. Sr-01000779333-4
128. Sr-01000779333-5
129. Sr-01000779333-7
130. Brd-k05236810-001-05-9
131. 23a002a4-b47b-46cd-848c-65042eacf3ff
132. Ncgc00142375-01,ncgc00142375-02
133. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4h-benzopyrone-4-one
134. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4h-chromen-4-one #
135. 4h-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-
Molecular Weight | 286.24 g/mol |
---|---|
Molecular Formula | C15H10O6 |
XLogP3 | 1.4 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 1 |
Exact Mass | 286.04773803 g/mol |
Monoisotopic Mass | 286.04773803 g/mol |
Topological Polar Surface Area | 107 Ų |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 447 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Luteolin has known human metabolites that include (2S,3S,4S,5R)-6-[5-(5,7-Dihydroxy-4-oxochromen-2-yl)-2-hydroxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid and Luteolin-7-glucuronide.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
A Luteolin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Luteolin, including repackagers and relabelers. The FDA regulates Luteolin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Luteolin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Luteolin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Luteolin supplier is an individual or a company that provides Luteolin active pharmaceutical ingredient (API) or Luteolin finished formulations upon request. The Luteolin suppliers may include Luteolin API manufacturers, exporters, distributors and traders.
click here to find a list of Luteolin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Luteolin DMF (Drug Master File) is a document detailing the whole manufacturing process of Luteolin active pharmaceutical ingredient (API) in detail. Different forms of Luteolin DMFs exist exist since differing nations have different regulations, such as Luteolin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Luteolin DMF submitted to regulatory agencies in the US is known as a USDMF. Luteolin USDMF includes data on Luteolin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Luteolin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Luteolin suppliers with USDMF on PharmaCompass.
Luteolin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Luteolin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Luteolin GMP manufacturer or Luteolin GMP API supplier for your needs.
A Luteolin CoA (Certificate of Analysis) is a formal document that attests to Luteolin's compliance with Luteolin specifications and serves as a tool for batch-level quality control.
Luteolin CoA mostly includes findings from lab analyses of a specific batch. For each Luteolin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Luteolin may be tested according to a variety of international standards, such as European Pharmacopoeia (Luteolin EP), Luteolin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Luteolin USP).
LOOKING FOR A SUPPLIER?